The breach concerns the dispensing error of the fast-release insulin pen NovoMix 30, rather than the woman’s usual slow-release pen Lantus Solostar.

Of the 33 that were drug-device combinations, 63% of those patents were related to the delivery devices rather than the insulin itself. Sanofi's Lantus (glargine) Solostar, for example, had 18 ...

According to a Kaiser Family Foundation analysis, 22% of Medicare Part D drug spending in 2021 went towards the 10 top-selling prescription drugs alone.

Tresiba and Lantus are both prescription drugs used to treat type 1 and type 2 diabetes. Learn how their uses, effectiveness, and side effects compare.

Basaglar and Lantus are drugs used to treat diabetes. Learn how they’re similar and different to help you decide if one may be right for you.

You discard the pen once the doses are used up (or the insulin expires, whichever happens first). The Tresiba prefilled pens are called FlexTouch, and the Lantus pens are called SoloStar.

Learn about alternatives and more for Toujeo SoloStar and Toujeo Max SoloStar (insulin glargine), which are prescription injections for diabetes.

Viatris wins US court decision on Sanofi’s appeals for Lantus patents invalidation Sanofi had appealed against all PTAB decisions that found the challenged claims unpatentable in April and May ...

A person tests the flow of a Sanofi Lantus brand SoloStar insulin pen in an arranged photograph taken April 5, 2019. Sanofi lost its appeals court bid to revive patents on the insulin pen in a victory ...